NSE: KRSNAA | BSE: 543328

Mid-range Performer

Download real time

600.50 1.40 (0.23%)

32.86% Fall from 52W High

12,923 NSE+BSE Volume

NSE 09 Apr, 2026 11:29 AM (IST)

1,947.9

Market Cap

Above industry Median

Beta 1Year

High Volatility

Krsnaa Diagnostics Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for KRSNAA, BSE:543328 Krsnaa Diagnostics Ltd.

Search Inside the pdf :

Krsnaa Diagnostics Ltd.

01 Sep 2025

600.50

0.23%

In Q1FY26, Krsnaa Diagnostics (Krsnaa) reported revenue of ?193 crores, up 13.4% YoY. EBITDA improved 20.5% YoY to ?51.4 crores, resulting in a margin expansion to 26.6% in Q1FY26 vs. 25.1% in Q1FY25, showing efficiency, cost controls, and disciplined execution across PPP and retail units.

Krsnaa Diagnostics has lost -27.34% in the last 6 Months

Krsnaa Diagnostics Ltd.

19 Feb 2025

600.50

0.23%

Maintaining a positive outlook whilst addressing short-term headwinds

Buy: Krsnaa Diagnostics Ltd.

Recommendation Target

Khambatta Securities

Krsnaa Diagnostics Limited’s (KDL’s) revenue decreased due to seasonal
factors and temporary operational issues. The Mumbai BMC project ended
earlier than expected, and the Maharashtra city and Madhya Pradesh MRI
installations experienced delays due to site handover issues which led to a
temporary dip in revenues.

Krsnaa Diagnostics Ltd. is trading above its 30 day SMA of 596.9

Krsnaa Diagnostics Ltd.

31 Oct 2024

600.50

0.23%

KRSNAA DIAGNOSTICS LTD.

Buy: Krsnaa Diagnostics Ltd.

Ventura

Bridging the Gap: Quality Diagnostics at Fair Prices

Number of FII/FPI investors decreased from 69 to 61 in Mar 2026 qtr

Krsnaa Diagnostics Ltd.

30 Oct 2024

600.50

0.23%

Expanding footprint and leveraging AI

Hold: Krsnaa Diagnostics Ltd.

Target

Khambatta Securities

Krsnaa Diagnostics Limited (KDL) reported robust business growth in 2Q FY25. The company has its growth projection of 25% for the financial year.

Krsnaa Diagnostics has lost -20.01% in the last 3 Months

Krsnaa Diagnostics Ltd.

23 Aug 2024

600.50

0.23%

Long-term potential is discounted into current valuations

Hold: Krsnaa Diagnostics Ltd.

Recommendation Target

Khambatta Securities

Krsnaa Diagnostics Limited’s (KDL’s) business growth remained healthy on a y-o-y basis. That said, the growth was lower than expectations.

Krsnaa Diagnostics Ltd. is trading above its 30 day SMA of 596.9

Krsnaa Diagnostics Ltd.

13 Feb 2022

600.50

0.23%

Krsnaa Diagnost

Buy: Krsnaa Diagnostics Ltd.

Target

Khambatta Securities

Krsnaa Diagnostics has lost -20.01% in the last 3 Months

Krsnaa Diagnostics Ltd.

03 Jan 2022

600.50

0.23%

Krsnaa Diagnost

Buy: Krsnaa Diagnostics Ltd.

Khambatta Securities

Krsnaa Diagnostics Ltd.'s price crossed below 30Day SMA today

Krsnaa Diagnostics Ltd.

04 Aug 2021

600.50

0.23%

Krsnaa Diagnostics Limited IPO Note

IPO Note: Krsnaa Diagnostics Ltd.

HDFC Securities

Krsnaa Diagnostics Limited IPO Note Issue Open: Aug 04 Aug 06 2021 Price Band: Rs. 933 954 (Discount of Rs 93 for the eligible employees) *Issue Size: 12,718,392 eq shares (Fresh Issue of 400 cr + Offer for sale of 8,525,520 eq sh) Issue Size: Rs.1186.6 1213.3 cr Reservation for: QIB atleast 75% eq sh Non Institutional atleast 15% eq sh Retail Upto 10% eq sh

Krsnaa Diagnostics Ltd.'s price crossed below 30Day SMA today

Krsnaa Diagnostics Ltd.

04 Aug 2021

600.50

0.23%

Krsnaa Diagnostics Ltd. IPO Note

IPO Note: Krsnaa Diagnostics Ltd.

Ashika Research

15 Equity Shares and in multiples thereof. Public issue of 12,718,392 Equity shares of Face value Rs. 5 each, (Comprising of fresh issue of 4,192,872 Equity Shares* (Rs. 400 cr.) and Offer for Sale of...